Organisations who have participated in, contributed to, or supported the development, evaluation or deployment of Sensabues’ EB technology.


  • Thermo Fisher Scientific, USA.


  • Partnership for Clean Competition, USA.
  • German Sport University Cologne, Institute of Biochemistry, Centre for Preventive Doping Research, Germany.

Drugs of Abuse:

  • Karolinska Institute, Sweden.
  • Karolinska University Hospital, Sweden.
  • National Institute of Drug Abuse, USA. 
  • UCSD, UC Center for Medicinal Cannabis Research, USA.       controlled trial of cannabis (Δ9-THC) 
  • Ghent University Hospital, Department of Laboratory Medicine, Belgium.
  • Hospital Pharmacy Gelre Hospitals, Apeldoorn/Zutphen, The Netherlands.
  • Department of Biochemistry and Neurobiology, AGH University of Science and Technology, Poland.
  • X-Pertise Consulting, France.
  • Västerås Hospital, Sweden.
  • Swedish Prison and Probation Service, Sweden.
  • Västervik Prison, Sweden.
  • LKAB, international mining and minerals conglomerate, Sweden.
  • SSAB, global steel producer, Sweden.

Therapeutic Drugs:

  • University of Liverpool, Institute of Translational Medicine, Liverpool Bioanalytical Facility, UK. 
  • Ghent University Hospital, Department of Laboratory Medicine, Belgium.
  • Jena University Hospital, Department of Clinical Chemistry and Laboratory Medicine, Germany.

Biomarkers and Metabolomics:

  • CB Med, Center for Biomarker Research in Medicine, Austria.
  • CEA Grenoble, Nanosafety Platform, Medical Biology Laboratory, France.
  • Karolinska University Hospital, Sweden.


  • Jinan University, Institute of Atmospheric Environmental Safety and Pollution Control, China.